132 related articles for article (PubMed ID: 24636273)
1. Calcium dysregulation, and lithium treatment to forestall Alzheimer's disease - a merging of hypotheses.
Wallace J
Cell Calcium; 2014 Mar; 55(3):175-81. PubMed ID: 24636273
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of lithium: intracellular signaling pathways].
Zorrilla Zubilete M
Vertex; 2003; 14(51):45-52. PubMed ID: 12690409
[TBL] [Abstract][Full Text] [Related]
3. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
Damri O; Shemesh N; Agam G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
5. Treatment of trauma with lithium to forestall the development of posttraumatic stress disorder by pharmacological induction of a mild transient amnesia.
Wallace J
Med Hypotheses; 2013 Jun; 80(6):711-5. PubMed ID: 23490200
[TBL] [Abstract][Full Text] [Related]
6. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
[TBL] [Abstract][Full Text] [Related]
7. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
8. Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
Stutzmann GE
Neuroscientist; 2005 Apr; 11(2):110-5. PubMed ID: 15746379
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: Mental plaque removal.
De Strooper B; Woodgett J
Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
[No Abstract] [Full Text] [Related]
10. Drug research: the ups and downs of lithium.
Pilcher HR
Nature; 2003 Sep; 425(6954):118-20. PubMed ID: 12968146
[No Abstract] [Full Text] [Related]
11. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
Bordji K; Becerril-Ortega J; Buisson A
Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789
[TBL] [Abstract][Full Text] [Related]
12. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
Avila J; Wandosell F; Hernández F
Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
[TBL] [Abstract][Full Text] [Related]
13. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
[TBL] [Abstract][Full Text] [Related]
14. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 prevents NMDA-induced neuronal Ca2+ overload via suppression of IP3 receptors.
Liu Z; Fang XX; Chen YP; Qiu YH; Peng YP
Brain Inj; 2013; 27(9):1047-55. PubMed ID: 23730923
[TBL] [Abstract][Full Text] [Related]
16. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder.
Yoon IS; Li PP; Siu KP; Kennedy JL; Cooke RG; Parikh SV; Warsh JJ
Mol Psychiatry; 2001 Nov; 6(6):678-83. PubMed ID: 11673796
[TBL] [Abstract][Full Text] [Related]
17. Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease.
Goñi-Oliver P; Avila J; Hernández F
J Alzheimers Dis; 2009; 18(4):843-8. PubMed ID: 19661623
[TBL] [Abstract][Full Text] [Related]
18. GSK-3 inhibitors for Alzheimer's disease.
Avila J; Hernández F
Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
[TBL] [Abstract][Full Text] [Related]
19. The use of the hippocampal slice preparation in the study of Alzheimer's disease.
Fitzjohn SM; Doherty AJ; Collingridge GL
Eur J Pharmacol; 2008 May; 585(1):50-9. PubMed ID: 18423442
[TBL] [Abstract][Full Text] [Related]
20. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.
Su Y; Ryder J; Li B; Wu X; Fox N; Solenberg P; Brune K; Paul S; Zhou Y; Liu F; Ni B
Biochemistry; 2004 Jun; 43(22):6899-908. PubMed ID: 15170327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
